Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant murine granulocyte-macrophage colony-stimulating factor
- Development stage
- Preclinical
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intravenous, Intraperitoneal
01
Overview
Recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) is a biologic research compound consisting of the murine form of the cytokine GM-CSF. Produced via recombinant DNA technology in systems such as *Escherichia coli* or *Saccharomyces cerevisiae*, it serves as a critical regulator of hematopoiesis. It primarily functions by stimulating the proliferation and differentiation of hematopoietic progenitor cells into granulocytes (neutrophils, eosinophils) and macrophages. Beyond its role in myelopoiesis, rmGM-CSF enhances the effector functions of mature myeloid cells, including phagocytosis and antimicrobial activity. It is extensively utilized in preclinical research to study recovery from myelosuppression, immune responses to bacterial and fungal pathogens, and as an adjuvant in cancer immunotherapy models.
- Other names
- murine GM-CSFmouse granulocyte-macrophage colony-stimulating factor
02
Targets
CSF2R (Granulocyte-macrophage colony-stimulating factor receptor)
Beyond the preview
Go deeper on recombinant murine granulocyte-macrophage colony-stimulating factor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant murine granulocyte-macrophage colony-stimulating factor.